Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects

Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects

COVID-19 vaccines have been instrumental tools in reducing the impact of SARS-CoV-2 infections around the world by preventing 80% to 90% of hospitalizations and deaths from reinfection, in addition to preventing 40% to 65% of symptomatic illnesses. However, the simultaneous large-scale vaccination o...

Bibliografske podrobnosti
Main Authors:	Rima Hajjo, Dima A. Sabbah, Alexander Tropsha
Format:	Article
Jezik:	English
Izdano:	MDPI AG 2022-06-01
Serija:	Pathogens
Teme:	COVID-19 mRNA vaccine informatics workflow SARS-CoV-2 systems biology vaccine adverse events
Online dostop:	https://www.mdpi.com/2076-0817/11/7/743

Podobne knjige/članki

The mRNA-LNP vaccines – the good, the bad and the ugly?
od: Botond Z. Igyártó, et al.
Izdano: (2024-02-01)

Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review
od: Rana I. Oueijan, et al.
Izdano: (2022-08-01)

Development of mRNA rabies vaccines
od: Zixin Fang, et al.
Izdano: (2024-12-01)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
od: Min Tang, et al.
Izdano: (2023-04-01)

Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP.
od: SIMONA BIANCHI, et al.
Izdano: (2022-01-01)

A cross-sectional study confirms temporary post-COVID-19 vaccine menstrual irregularity and the associated physiological changes among vaccinated women in Jordan
od: Ensaf Y. Almomani, et al.
Izdano: (2023-10-01)

Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination
od: Oleguer Parés-Badell, et al.
Izdano: (2022-07-01)

Characteristics of Persistent Symptoms Manifested after SARS-CoV-2 Vaccination: An Observational Retrospective Study in a Specialized Clinic for Vaccination-Related Adverse Events
od: Kazuki Tokumasu, et al.
Izdano: (2023-10-01)

An Update on mRNA-Based Viral Vaccines
od: Subbiah Jeeva, et al.
Izdano: (2021-08-01)

Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns
od: Dimitra S. Mouliou, et al.
Izdano: (2022-06-01)

Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
od: Qi Ma, et al.
Izdano: (2025-01-01)

Immunogenicity of the Two mRNA SARS-CoV-2 Vaccines in a Large Cohort of Dialysis Patients
od: Paraskevi Tsoutsoura, et al.
Izdano: (2022-11-01)

Adverse Events Following BNT162b2 mRNA COVID-19 Vaccine Immunization among Healthcare Workers in a Tertiary Hospital in Johor, Malaysia
od: Aie Yen Tan, et al.
Izdano: (2022-03-01)

Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection
od: Oleguer Parés-Badell, et al.
Izdano: (2021-12-01)

Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
od: Ziqi Cheng, et al.
Izdano: (2024-12-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
od: Amparo L. Figueroa, et al.
Izdano: (2025-12-01)

A Letter to the Editor Regarding ‘Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-analysis Using the GRADE Framework’
od: Hannah R. Volkman, et al.
Izdano: (2024-08-01)

A Cross-Sectional Study to Assess mRNA-COVID-19 Vaccine Safety among Indian Children (5–17 Years) Living in Saudi Arabia
od: Marya Ahsan, et al.
Izdano: (2023-01-01)

mRNA Technology and Mucosal Immunization
od: Antonio Toniolo, et al.
Izdano: (2024-06-01)

An mRNA vaccine against rabies provides strong and durable protection in mice
od: Miao Li, et al.
Izdano: (2023-10-01)

The mRNA vaccine, a swift warhead against a moving infectious disease target
od: Sheema Mir, et al.
Izdano: (2024-12-01)

COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing
od: Santiago Grau, et al.
Izdano: (2022-04-01)

Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty<sup>®</sup>)
od: Jürgen Held, et al.
Izdano: (2021-09-01)

RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
od: Mohammad Natami, et al.
Izdano: (2024-03-01)

Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19
od: Shehzad M. Iqbal, et al.
Izdano: (2024-08-01)

Propensity-Score-Matched Evaluation of Adverse Events Affecting Recovery after COVID-19 Vaccination: On Adenovirus and mRNA Vaccines
od: Chang-Sik Son, et al.
Izdano: (2022-02-01)

Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines
od: Teresa Aydillo, et al.
Izdano: (2024-12-01)

Comparison of Immune Responses between Inactivated and mRNA SARS-CoV-2 Vaccines Used for a Booster Dose in Mice
od: Ning Luan, et al.
Izdano: (2023-06-01)

Side Effects of mRNA-Based COVID-19 Vaccines among Young Adults (18–30 Years Old): An Independent Post-Marketing Study
od: Abanoub Riad, et al.
Izdano: (2021-10-01)

Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients
od: Rima Hajjo, et al.
Izdano: (2021-10-01)

Post-RNA (mRNA) Vaccination Myocarditis: CMR Features
od: Karuna M. Das, et al.
Izdano: (2022-04-01)

Effectiveness of mRNA COVID-19 Vaccination on SARS-CoV-2 Infection and COVID-19 in Sicily over an Eight-Month Period
od: Emanuele Amodio, et al.
Izdano: (2022-03-01)

Combinative workflow for mRNA vaccine development
od: Renuka Khanzode, et al.
Izdano: (2024-09-01)

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
od: Girolamo Giannotta, et al.
Izdano: (2023-03-01)

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
od: Alireza Shariati, et al.
Izdano: (2024-12-01)

Editorial: Building public confidence in innovative mRNA vaccines
od: Jia Hu, et al.
Izdano: (2025-01-01)

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
od: Vivek P. Chavda, et al.
Izdano: (2023-02-01)

Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study
od: Bálint Drácz, et al.
Izdano: (2022-12-01)

Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
od: Yusi Wang, et al.
Izdano: (2022-02-01)

mRNA vaccine in cancer therapy: Current advance and future outlook
od: Youhuai Li, et al.
Izdano: (2023-08-01)